Primary refractory young myeloma: a difficult clinical situation - YouTube
L'ARC soutient les recherches menées à l'IRCL - IRCL
GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer
Un médecin de Lille reçoit 50 000 euros pour ses recherches contre le cancer de la moelle osseuse | Lille Actu
Pr Salomon MANIER - Auteur | Edimark
Faculty – The 9th COMy World Congress
Dr. Karma Salem, MD – Atlanta, GA | Radiology
Therapy of relapsed-refractory multiple myeloma - Springer Healthcare IME
Pr Salomon MANIER - Auteur | Edimark
L'ARC soutient les recherches menées à l'IRCL - IRCL
Pr Salomon MANIER - Auteur | Edimark
IACH on Twitter: "Join us TODAY at 2pm Eastern Time (Atlanta), 8pm CET (Paris) for live news from #ASH21 with Dr. Salomon Manier and @Mohty_EBMT Register Free here: https://t.co/bdQmP2b0TS https://t.co/oYQD70BBZf" / Twitter
Daniel Auclair on Twitter: "Great panel on #myeloma precursor conditions @AACR #AACRMDT21 meeting with @IreneGhobrial @DrOlaLandgren @mvmateos @JHillengass and Salomon Manier #mmsm https://t.co/dls0ZEaoFE" / Twitter
ASH 2022: Multiple Myeloma Highlights - The ASCO Post
Massimo Corsaro (@Massimo_Pfizer) / Twitter
The CARAMBA team | CARAMBA
ide-cel and neurotoxicity | Int'l Myeloma Foundation
Salomon Manier's research works | Centre Hospitalier Universitaire de Nancy, Laxou (CHU Nancy) and other places
Antibody-drug Conjugates in Relapsed/Refractory Multiple Myeloma: from Bench to Bedside - Springer Healthcare IME
Michaela REAGAN | Professor (Associate) | BS, PhD | Research profile
ide-cel and neurotoxicity | Int'l Myeloma Foundation
L'ARC soutient les recherches menées à l'IRCL - IRCL
Pr Salomon MANIER - Auteur | Edimark
GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
☎️ Contacts du Dr Salomon Manier, Hematologue à Lille 59000
